Calamos Advisors’s CryoPort CYRX Stock Holding History

Calamos Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27,825	Closed	-$1.65M	–	1176
2021 Q4	$1.65M	Buy	+27,825	New	+$1.93M	0.01%	930

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Calamos Advisors's CYRX Position: Q1 2022 in Review

Calamos Advisors sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 27,825 shares — an estimated $1.65M sold.

Calamos Advisors first reported a position in CYRX in Q4 2021 and held it in 1 quarter. The position peaked at $1.65M in Q4 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

Calamos Advisors reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
Calamos Advisors sold 27,825 CryoPort shares in Q1 2022, an estimated $1.65M.
Calamos Advisors first reported a position in CryoPort in Q4 2021 and held it in 1 quarter.
Calamos Advisors's CryoPort position peaked at $1.65M in Q4 2021.
200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.